Jupiter Neurosciences, Inc. (JUNS)
NASDAQ·Healthcare·Biotechnology
$0.37
+1.54%
Mkt Cap $14.60M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 1, 2026 | $75.00K | $21.80K | -70.94% | -$0.07 | -$0.07 | +0.00% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.08 | -$0.07 | +12.50% | — | — |
| Q3 2025 Aug 18, 2025 | — | — | — | -$0.07 | -$0.07 | +0.00% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.03 | -$0.05 | -66.67% | — | — |
| Q1 2025 Mar 28, 2025 | — | — | — | -$0.02 | -$0.05 | -150.00% | — | — |
| Q4 2024 Dec 23, 2024 | — | — | — | — | -$0.02 | — | — | — |
| Q2 2024 Jun 30, 2024 | — | — | — | — | $0.01 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.02 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.01 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.07 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.03 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.04 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $233.28K | — | — | -$0.08 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.07 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.23 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.14 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $264.27K | — | — | -$0.09 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $373.77K | — | — | -$0.03 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $1.03M | — | — | -$0.05 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | $101.00K | — | — | -$0.06 | — | — | — |